AnodyneWiki

Ergonovine

Ergonovine
Ergonovine
Salts
[]
Ergonovine maleate
Ergonovine maleate
Ergonovine hemitartrate
Ergonovine hemitartrate
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass325.40 g/mol [1]
AppearancePlates or needles [1]
Melting point162 °C [1]
DecompositionWhen heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1]
Solubility2.68 mg/mL at 25 °C [1]
Predicted LogP1.8 [1]
Structural Identifiers
[]
Molecular formulaC19H23N3O2
IUPAC name(6aR,9R)-N-[(2S)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
SMILESC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
InChIInChI=1S/C19H23N3O2/c1-11(10-23)21-19(24)13-6-15-14-4-3-5-16-18(14)12(8-20-16)7-17(15)22(2)9-13/h3-6,8,11,13,17,20,23H,7,9-10H2,1-2H3,(H,21,24)/t11-,13+,17+/m0/s1
InChIKeyWVVSZNPYNCNODU-XTQGRXLLSA-N
CAS number60-79-7
UNIIWH41D8433D
PubChem CID443884
Pharmacokinetics[]
Elimination half-life2-phase (10 min; 2 hours)
MetabolismLiver (partly CYP3A4)
ExcretionBile duct
Routes of administrationoral, intramuscular, intravenous

Ergonovine (also known as Ergobasine, Ergotocine, Ergostetrine, Margonovine, Ergoklinine, Ergometrin, Ergometrina, Secacornin, Ergometrinum or Secometrin) is a substance of the lysergamide class.

Chemistry

Salts []

Ergonovine is typically found in the form of its maleate and hemitartrate salts.

 []

Ergonovine is a single defined stereoisomer.

Ergonovine matches Lipinski's rule of five.

There are currently 2 reagent-interactions on

ReagentColor changeDescription
Ehrlichpurple
Hofmannblue

Pharmacology

Mechanism of action []

Ergonovine directly stimulates the uterine muscle to increase force and frequency of contractions. With usual doses, these contractions precede periods of relaxation; with larger doses, basal uterine tone is elevated and these relaxation periods will be decreased. Contraction of the uterine wall around bleeding vessels at the placental site produces hemostasis. Ergonovine also induces cervical contractions. The sensitivity of the uterus to the oxytocic effect is much greater toward the end of pregnancy. The oxytocic actions of ergonovine are greater than its vascular effects. Ergonovine, like other ergot alkaloids, produces arterial vasoconstriction by stimulation of alpha-adrenergic and serotonin receptors and inhibition of endothelial-derived relaxation factor release. It is a less potent vasoconstrictor than ergotamine. As a diagnostic aid (coronary vasospasm), ergonovine causes vasoconstriction of coronary arteries. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

induction / metabolism / inhibition69 (9 contraindicated)
shared target2
shared target2
shared target2
shared target1
shared target1
shared target1

Medical side effects []

36 side effects listed on drug labels in (ergonovine).

  • Abdominal pain
  • Gastrointestinal pain
  • Chest pain
  • Arteriospasm coronary
  • Diarrhoea
  • Dizziness
  • Dyspnoea
  • Oesophageal spasm
  • Gangrene
  • Hallucination
  • Headache
  • Haematuria
  • Hypertension
  • Hypotension
  • Muscle spasms
  • Myasthenia gravis
  • Myocardial infarction
  • Acute coronary syndrome
  • Nasal congestion
  • Nausea
  • Palpitations
  • Pulmonary oedema
  • Shock
  • Hyperhidrosis
  • Thrombophlebitis
  • Tinnitus
  • Vertigo
  • Vomiting
  • Water intoxication
  • Ventricular arrhythmia
  • Vasospasm
  • Intestinal infarction
  • Pleural fibrosis
  • Bradycardia
  • Drug interaction
  • Intestinal ischaemia

Indications

  • Post abortion haemorrhage
  • Postpartum haemorrhage
  • Uterine atony

 []

  • Brazil: Ergonovine is a D1.[3]
  • Canada: Ergonovine is a Schedule VI.
  • United States: Ergonovine is a Rx only.

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 443884, Ergonovine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/443884
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ergonovine. UNII: WH41D8433D. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/WH41D8433D
  3. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 03:05:37
drugsprook2026-11-20 03:05:33
erowidmissing (no Erowid substance of that name)2026-11-20 03:05:33
gsrsok2026-11-20 03:05:35
hmdbmissing (hmdb.ca refused automated access to HMDB0015383)2026-11-20 03:05:33
keggok2026-11-20 03:05:35
pubchemok2026-11-20 03:05:33
redditmissing (no r/tripreports posts mention it)2026-11-20 03:05:33
siderok2026-11-20 03:05:33
structureok2026-11-20 03:05:33
wikipediaok2026-11-20 03:05:34